Literature DB >> 3537191

Helodermatine, a kallikrein-like, hypotensive enzyme from the venom of Heloderma horridum horridum (Mexican beaded lizard).

A Alagon, L D Possani, J Smart, W D Schleuning.   

Abstract

We have purified and characterized the major N-benzoyl-L-arginine ethyl ester hydrolase from the venom of Heloderma horridum horridum. The enzyme belongs to the serine proteinase family, and its activity vs. peptide amide substrates and human high-molecular-weight kininogen suggests a similarity to the family of kallikreins. This interpretation is corroborated by its reactivity with the natural inhibitors soybean trypsin inhibitor and Kunitz-type bovine pancreatic trypsin inhibitor (aprotinin). Injection of the enzyme (2-16 micrograms/kg) into anesthetized rabbits leads to a rapid dose-dependent transient decrease of the arterial blood pressure. Like glandular kallikrein it specifically converts single-chain tissue type plasminogen activator into its double chain form. In contrast to other kallikrein-like enzymes from snake venoms it shows no thrombin-like or plasminogen activator activity. The enzyme is a single-chain glycoprotein (Mr 63,000). The N-terminal sequence revealed significant homology to pig pancreatic kallikrein and to kallikrein like enzymes from Crotalus atrox and Crotalus adamanteus venom. This enzyme, which we name Helodermatine, is the first purified from Sauria with kallikrein-like properties.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3537191      PMCID: PMC2188495          DOI: 10.1084/jem.164.6.1835

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  18 in total

1.  The determination of enzyme inhibitor constants.

Authors:  M DIXON
Journal:  Biochem J       Date:  1953-08       Impact factor: 3.857

2.  Determination of the operational molarity of solutions of bovine alpha-chymotrypsin, trypsin, thrombin and factor Xa by spectrofluorimetric titration.

Authors:  G W Jameson; D V Roberts; R W Adams; W S Kyle; D T Elmore
Journal:  Biochem J       Date:  1973-01       Impact factor: 3.857

3.  Structure of mouse kallikrein gene family suggests a role in specific processing of biologically active peptides.

Authors:  A J Mason; B A Evans; D R Cox; J Shine; R I Richards
Journal:  Nature       Date:  1983-05-26       Impact factor: 49.962

4.  The primary structure of crotalase, a thrombin-like venom enzyme, exhibits closer homology to kallikrein than to other serine proteases.

Authors:  H Pirkle; F S Markland; I Theodor; R Baumgartner; S S Bajwa; H Kirakossian
Journal:  Biochem Biophys Res Commun       Date:  1981-03-31       Impact factor: 3.575

5.  A gas-liquid solid phase peptide and protein sequenator.

Authors:  R M Hewick; M W Hunkapiller; L E Hood; W J Dreyer
Journal:  J Biol Chem       Date:  1981-08-10       Impact factor: 5.157

6.  The primary structure of porcine glandular kallikreins.

Authors:  H Tschesche; G Mair; G Godec
Journal:  Adv Exp Med Biol       Date:  1979       Impact factor: 2.622

7.  An enzymatic function associated with transformation of fibroblasts by oncogenic viruses. I. Chick embryo fibroblast cultures transformed by avian RNA tumor viruses.

Authors:  J C Unkeless; A Tobia; L Ossowski; J P Quigley; D B Rifkin; E Reich
Journal:  J Exp Med       Date:  1973-01-01       Impact factor: 14.307

8.  Venom from two sub-species of Heloderma horridum (Mexican beaded lizard): general characterization and purification of N-benzoyl-L-arginine ethyl ester hydrolase.

Authors:  A C Alagón; M E Maldonado; J Z Juliá; C R Sánchez; L D Possani
Journal:  Toxicon       Date:  1982       Impact factor: 3.033

9.  Biochemical characterization of the lizard toxin gilatoxin.

Authors:  R A Hendon; A T Tu
Journal:  Biochemistry       Date:  1981-06-09       Impact factor: 3.162

10.  [Isolation and properties of a kallikrein from the venom of the Gila monster, Heloderma suspectum].

Authors:  D Mebs
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1969-07
View more
  2 in total

1.  Varanid Lizard Venoms Disrupt the Clotting Ability of Human Fibrinogen through Destructive Cleavage.

Authors:  James S Dobson; Christina N Zdenek; Chris Hay; Aude Violette; Rudy Fourmy; Chip Cochran; Bryan G Fry
Journal:  Toxins (Basel)       Date:  2019-05-07       Impact factor: 4.546

Review 2.  Neglected Venomous Animals and Toxins: Underrated Biotechnological Tools in Drug Development.

Authors:  Guilherme Rabelo Coelho; Daiane Laise da Silva; Emidio Beraldo-Neto; Hugo Vigerelli; Laudiceia Alves de Oliveira; Juliana Mozer Sciani; Daniel Carvalho Pimenta
Journal:  Toxins (Basel)       Date:  2021-11-29       Impact factor: 4.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.